Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
White Mountains Insurance
WTM
$5.06B
| $27M | 0.04% |
30,700
+13,100
| +74% | +$11.7M |
|
627
Prestige Consumer Healthcare
PBH
$2.48B
| $27M | 0.04% |
486,000
+94,500
| +24% | +$5.21M |
|
628
Sociedad Química y Minera de Chile
SQM
$20.4B
| $27M | 0.04% |
785,500
+29,600
| +4% | +$963K |
|
629
Spire
SR
$4.89B
| $27M | 0.04% |
399,700
+94,100
| +31% | +$6.12M |
|
|
MSCC
630
DELISTED
Microsemi Corp
MSCC
| $26.9M | 0.04% |
522,301
+245,300
| +89% | +$13.2M |
|
631
Helios Technologies
HLIO
$2.67B
| $26.9M | 0.04% |
744,875
+108,275
| +17% | +$4.06M |
|
|
LKFT
632
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $26.8M | 0.04% |
311,200
+105,700
| +51% | +$7.61M |
|
633
Advanced Energy
AEIS
$13.5B
| $26.8M | 0.04% |
391,200
+11,800
| +3% | +$729K |
|
634
Adtran
ADTN
$665M
| $26.8M | 0.04% |
1,291,528
+117,900
| +10% | +$2.56M |
|
635
Pinnacle West Capital
PNW
$12.2B
| $26.7M | 0.04% |
320,700
+52,700
| +20% | +$4.21M |
|
|
PHH
636
DELISTED
PHH Corporation
PHH
| $26.7M | 0.04% |
2,095,800
+364,300
| +21% | +$4.95M |
|
637
Baidu
BIDU
$35.6B
| $26.6M | 0.04% |
+154,451
| New | +$27.2M |
|
638
AMC Entertainment Holdings
AMC
$2.26B
| $26.6M | 0.04% |
84,529
-39,230
| -32% | -$12.5M |
|
639
Central Pacific Financial
CPF
$997M
| $26.5M | 0.04% |
866,153
-81,300
| -9% | -$2.52M |
|
640
Labcorp
LH
$26.2B
| $26.4M | 0.04% |
214,531
+135,612
| +172% | +$16.1M |
|
641
Tower Semiconductor
TSEM
$29.4B
| $26.4M | 0.04% |
1,145,186
+247,500
| +28% | +$5.43M |
|
642
Essex Property Trust
ESS
$18.1B
| $26.4M | 0.04% |
114,000
+107,000
| +1,529% | +$24.5M |
|
643
Philips
PHG
$26.2B
| $26.4M | 0.04% |
1,109,232
+62,764
| +6% | +$1.41M |
|
644
Natural Health Trends
NHTC
$15.4M
| $26.3M | 0.04% |
909,700
+22,300
| +3% | +$599K |
|
|
PINC
645
DELISTED
Premier
PINC
| $26.2M | 0.04% |
824,600
-379,200
| -32% | -$11.9M |
|
|
CUDA
646
DELISTED
Barracuda Networks, Inc.
CUDA
| $26.2M | 0.04% |
1,135,695
+443,495
| +64% | +$10.4M |
|
|
PGTI
647
DELISTED
PGT, Inc.
PGTI
| $26.2M | 0.04% |
2,435,229
-167,200
| -6% | -$1.84M |
|
648
Waters Corp
WAT
$40.9B
| $26.2M | 0.04% |
167,400
-27,900
| -14% | -$4.17M |
|
649
UBS Group
UBS
$177B
| $26.1M | 0.04% |
1,636,600
+540,799
| +49% | +$8.7M |
|
650
Arista Networks
ANET
$265B
| $26.1M | 0.04% |
3,153,600
-4,651,200
| -60% | -$32.1M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.